Antimalarial Potential of Leaves of Chenopodium Ambrosioides L
Overview
Authors
Affiliations
In an effort to identify novel therapeutic alternatives for the treatment of malaria, the present study evaluated the antimalarial effect of the crude hydroalcoholic extract (HCE) from the leaves of Chenopodium ambrosioides L. For this purpose, the molecular affinity between the total proteins from erythrocytes infected with Plasmodium falciparum and HCE or chloroquine was evaluated by surface plasmon resonance (SPR). Subsequently, the plasmodicidal potential of HCE was assessed in a P. falciparum culture. Using BALB/c mice infected with Plasmodium berghei intraperitoneally (ip.), we evaluated the effects of ip. treatment, for three consecutive days (day 7, 8, and 9 after infection), with chloroquine (45 mg/kg) or HCE (5 mg/kg), considering the survival index and the parasitaemia. The groups were compared to an untreated control group that receives only PBS at the same periods. The results indicated that HCE could bind to the total proteins of infected erythrocytes and could inhibit the parasite growth in vitro (IC = 25.4 g/mL). The in vivo therapeutic treatment with HCE increased the survival and decreased the parasitaemia in the infected animals. Therefore, the HCE treatment exhibited a significant antiplasmodial effect and may be considered as a potential candidate for the development of new antimalarial drugs.
The Paradigm Shift of Using Natural Molecules Extracted from Northern Canada to Combat Malaria.
Bourgeois A, Lemos J, Roucheray S, Sergerie A, Richard D Infect Dis Rep. 2024; 16(4):543-560.
PMID: 39051241 PMC: 11270350. DOI: 10.3390/idr16040041.
Seguin J, Gagnon D, Belanger S, Richard D, Fernandez X, Boudreau S ACS Omega. 2023; 8(19):16729-16737.
PMID: 37214733 PMC: 10193425. DOI: 10.1021/acsomega.3c00235.
Salt-Tolerant Plants as Sources of Antiparasitic Agents for Human Use: A Comprehensive Review.
Rodrigues M, Pereira C, Oliveira M, Zengin G, Custodio L Mar Drugs. 2023; 21(2).
PMID: 36827107 PMC: 9967096. DOI: 10.3390/md21020066.
Kandsi F, Elbouzidi A, Zahra Lafdil F, Meskali N, Azghar A, Addi M Antibiotics (Basel). 2022; 11(4).
PMID: 35453233 PMC: 9031865. DOI: 10.3390/antibiotics11040482.
Ceravolo I, Aguiar A, Adebayo J, Krettli A Front Pharmacol. 2021; 12:734263.
PMID: 34630109 PMC: 8493299. DOI: 10.3389/fphar.2021.734263.